Prolongation of skin allograft survival is associated with reduced Th1 cytokine responses in the WKY→F344 rat model

Transplantation

Volumn 68, Issue 9, 1999, Pages 1393-1401

  Nicolaidou, Electra ^a   Okada, Yoshinori ^a   Zuo, Xiao Jing ^a   Toyoda, Mieko ^a   Marchevsky, Alberto ^a   Matloff, Jack ^a   Jordan, Stanley C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; GRAFT SURVIVAL; HELPER CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLOGRAFT; T LYMPHOCYTE SUBPOPULATION;

EID: 0033571519     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199911150-00028     Document Type: Article

References (53)

1. Katz SM, Cramer DV, Kunz HW, Gill TJ III. Effect of major histocompatibility complex genetic disparities on cardiac and skin graft rejection in the rat. Transplantation 1983; 36: 463.
2. Vriens PW, Nisco SJ, Grant Hoyt E, et al. Tissue-specific differences in the establishment of tolerance: tolerogenic effects of lung allografts in rats. Transplantation 1994; 57: 1795.
3. Bishop GA, Sun J, DeCruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996; 156: 4925.
4. Kondo T, Marchevsky AM, Prehn J, Matloff JM, Waters PF, Jordan SC. Evidence of complete tolerance in a model of rat lung transplants. Transplantation 1991; 52: 928.
5. Matsumura Y, Marchevsky A, Zuo X-J, Kass RM, Matloff JM, Jordan SC. Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation. Transplantation 1995; 59: 1509.
6. Zuo X-J, Matsumura Y, Prehn J, et al. Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCR. Transplant Immunol 1995; 3: 151.
7. Bergstresser PR, Cruz PD Jr., Niederkorn JY, Takashima A. Third international workshop on Langerhans cells: discussion overview. J Invest Dermatol 1992; 99: 1S.
8. Steinman R, Hoffman L, Pope M. Maturation and migration of cutaneous dendritic cells. J Invest Dermatol 1995; 105: 2S.
9. Richters CD, van Pelt AM, van Geldrop E, et al. Migration of rat skin dendritic cells. J Leukocyte Biol 1996; 60: 317.
10. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271.
11. + T cells. J Exp Med 1997; 185: 2133.
12. Johnson JG, Jenkins MK. Co-stimulatory functions of antigen-presenting cells. J Invest Dermatol 1992; 99: 62S.
13. Yokozeki H, Katayama I, Ohki O, et al. Functional CD86 (B7-2/B70) on cultured human Langerhans cells. J Invest Dermatol 1996; 106: 147.
14. + T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15: 297.
15. Nickerson P, Steiger J, Zheng XX, et al. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation 1997; 63: 489.
16. Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK. Are Th2 helper T lymphocytes beneficial, deleterious or irrelevant in promoting allograft survival? Transplantation 1997; 63: 619.
17. Chen N, Field EH. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation 1995; 59-933.
18. Gorczynski RM. Regulation of IFN-γ and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell Immunol 1995; 160-224.
19. Rosenberg AS. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
20. Doody DP, Stenger KS, Winn HJ. Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts. J Exp Med 1994; 179: 1645.
21. Bhan AK, Mihm MC Jr, Dvorak HF. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol 1982; 129: 1578.
22. Mayer TG, Bhan AK, Winn HJ. Immunohistochemical analyses of skin graft rejection in mice: kinetics of lymphocyte infiltration in grafts of limited immunogenetic disparity. Transplantation 1988; 46: 890.
23. Kobayashi E, Kawai K, Ito M, Matsumoto Y, Fujiwara M. Mechanism of rejection of MHC class I-disparate murine skin grafts: histological and immunohistochemical studies of the rejection phenomenon. Transplant Proc 1990; 22: 2352.
24. Kobayashi E, Fujiwara M. Mechanism of rejection of MHC class II-disparate murine skin grafts. I. Immunohistochemical analysis of T-cell subsets infiltrating the site of the graft. Transplant Proc 1992; 24: 419.
25. Stevens HPJD, van der Kwast TH, van der Meide PH, Vuzevski VD, Buurman WA, Jonker M. Synergistic immunosuppressive effects of monoclonal antibodies specific for interferon-γ and tumor necrosis factor α. Transplantation 1990; 50: 856.
26. Raju GP, Belland SE, Eisen HJ. Prolongation of cardiac allograft survival with transforming growth factor-β1 in rats. Transplantation 1994; 58: 392.
27. Hsiao L, Takeya M, Arao T, Takahashi K. An immunohistochemical and immunoelectron microscopic study of the ontogeny of rat Langerhans cell lineage with anti-macrophage and anti-Ia monoclonal antibodies. J Invest Dermatol 1989; 93: 780.
28. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
29. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
30. Thai NL, Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation: graft rejection is associated with augmented Th1 function. Transplantation 1995; 59: 274.
31. Ozasa T, Newton MR, Dallman MJ, Shimizu S, Gray DWR, Morris PJ. Cytokine gene expression in pancreatic islet grafts in the rat. Transplantation 1997; 64: 1152.
32. Mottram PL, Han W-R, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59: 559.
33. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
34. + lymphocytes from CD8 -/-mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 1996; 156: 4114.
35. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
36. Sun J, McCaughan GW, Matsumoto Y, Sheil AGR, Gallagher ND, Bishop GA. Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994; 57: 1349.
37. Chen N, Gao Q, Field EH. Prevention of Th1 responses is critical for tolerance. Transplantation 1996; 61: 1076.
38. Gorczynski RM, Hozumi N, Wolf S, Chen Z. Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immunization. Transplantation 1995; 60: 1337.
39. Qin L, Chavin KD, Ding Y, et al. Gene transfer for transplantation: prolongation of allograft survival with transforming growth factor-β1. Ann Surg 1994; 220: 508.
40. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15: 749.
41. Wettstein PJ, Korngold R. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens. Transplantation 1992; 54: 296.
42. Rolstad B, Vaage JT. The role of natural killer cells in allograft responses to MHC antigens in the rat. Res Immunol 1997; 148: 159.
43. lck. Eur J Immunol 1995; 25: 3155.
44. Drebke B, Zhu X, Peters J, Brotzmann K, Fandrich F. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation. Transplant Proc 1996; 28: 3259.
45. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483.
46. Chen H-D, Ma C, Yuan J-T, Wang Y-K, Silvers WK. Occurrence of donor Langerhans cells in mouse and rat chimeras and their replacement in skin grafts. J Invest Dermatol 1986; 86: 630.
47. Demarchez M, Asselineau D, Czernielewski J Migration of Langerhans cells into human epidermis of "reconstructed" skin, normal skin, or healing skin, after grafting onto the nude mouse. J Invest Dermatol 1993; 100: 648.
48. Shirwan H, Makowka L, Blankenhorn EP, Cramer DV. Polymerase chain reaction detection of chimerism in rats based on an allelic polymorphism for T cell antigen receptor Cβ genes. Transplant Immunol 1994; 2: 253.
49. Charlton B, Auchincloss H Jr., Fathman CG. Mechanisms of transplantation tolerance. Annu Rev Immunol 1994; 12: 707.
50. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1065.
51. Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
52. Koide J, Engleman EG. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. J Immunol 1990; 144: 32.
53. Austyn JM, Larsen CP. Migration patterns of dendritic leukocytes: implications for transplantation. Transplantation 1990; 49: 1.